Viewing Study NCT00056459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-14 @ 5:11 AM
Study NCT ID: NCT00056459
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2003-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Neoplasms View
None Colonic Neoplasms View
None Rectal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal Cancer View
None PTK787 View
None Vatalanib View
None VEGF inhibitor View
None Oxaliplatin View
None Angiogenesis View
None Rectal Cancer View
None Colon Cancer View
None Colorectal Carcinoma View
None Colorectal Tumor View